NAMS NewAmsterdam Pharma Company NV Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

NAMS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NAMS
(Try 14 days for Free)

View a ticker or compare two or three

Compare

NAMS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NAMS
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

NAMS is expected to report earnings to rise 164.56% to -47 cents per share on March 28

NewAmsterdam Pharma Company NV NAMS Stock Earnings Reports

Q4'24

Est.

$-0.48

Q3'24

Beat

by $0.32

Q2'24

Beat

by $0.17

Q1'24

Missed

by $0.44

Q4'23

Beat

by $0.04

The last earnings report on November 06 showed earnings per share of -18 cents, beating the estimate of -49 cents. With 846.72K shares outstanding, the current market capitalization sits at 2.31B.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Gooimeer 2-35

Phone

+31 352062971

Employees

Web

https://www.newamsterdampharma.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	27.37	0.91	+3.44%
GameStop Corp
AAPL	228.22	3.10	+1.38%
Apple
SPY	593.35	-3.84	-0.64%
SPDR® S&P 500® ETF Trust
BTC.X	87250.430000	-3333.734400	-3.68%
Bitcoin cryptocurrency
TSLA	311.18	-19.06	-5.77%
Tesla

NAMS and Stocks

Correlation & Price change

A.I.dvisor tells us that NAMS and GYRE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NAMS and GYRE's prices will move in lockstep.

Ticker / NAME	Correlation To NAMS	1D Price Change %
NAMS	100%	-0.65%
GYRE - NAMS	31% Poorly correlated	-9.56%
SPHDF - NAMS	31% Poorly correlated	N/A
SANA - NAMS	25% Poorly correlated	-6.34%
SLN - NAMS	24% Poorly correlated	-5.98%
SLNCF - NAMS	24% Poorly correlated	+3.39%
More